Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study.

Int J Surg · 2023 · PMC10651289 · PMID 37578492

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

marginally significantP =0.08so close (0.05 < p ≤ 0.1)

Consistently, in the external validation cohort, a marginally significant benefit from adjuvant therapy was observed only in group 5 (HR=0.324, 95% CI: 0.092–1.143, P =0.08) (Supplementary Table 6, Supplemental Digital Content 1, http://links.lww.com/JS9/A863 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.